Lakefront Biotherapeutics N.V.
Support and Resistance Levels
Past performance
News About LKFT
All events for LKFT
All deals for LKFT
Financial Ratios
Financial Statements
LKFT vs Sector & Peers
About Lakefront Biotherapeutics N.V.
Galapagos NV is a biotechnology company that specializes in the discovery and advancement of novel small molecule and antibody-based therapeutics. Its active clinical development programs include drugs like filgotinib and GLP3667, alongside the Toledo program and therapies targeting idiopathic pulmonary fibrosis. The firm was established on June 30, 1999, by co-founders Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es, and maintains its headquarters in Mechelen, Belgium. Website galapagos.com
Headquarters Mechelen, BE